Sheltagen Medical For Profit

Sheltagen Medical develops and promotes a method of human bone generation in laboratory conditions. It provides human bone tissue for implantation in patients with bone fractures or spinal instability. The product is patient-specific, using the patientвАЩs own bone cells and blood components so that the transplant will not be rejected by the patientвАЩs body. The company's methodology for bone production in the laboratory involves autologous bone cells seeded on inorganic matrix, cultured in media containing self-blood serum, and exposed to mechanical stimulation by vibration.

Headquarters: Haifa, Hefa, Israel
Technology: Stem cells
Industry: Regenerative Medicine